Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-03-10
1986-01-07
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
045634610
ABSTRACT:
Method of blocking 5HT.sub.2 without effect on alpha receptors with 1-loweralkyl-6-methyl-8.beta.-(hydroxy)alkoxy carbonyl-5R-ergolines.
REFERENCES:
patent: 3113133 (1963-12-01), Hofmann et al.
patent: 3228941 (1966-01-01), Bernardi et al.
patent: 3249617 (1966-05-01), Hofmann et al.
patent: 3580916 (1971-05-01), Garbrecht
patent: 4230859 (1980-10-01), Rucman
Cohen et al., Chem. Abst. 100: 18298w, (1983).
Cassady et al., J. of Med. Chem., vol. 17, No. 3, (Mar. 1974), pp. 300-307.
Goodman and Gilman, The Pharmacologic Basis of Therapeutics, (6th Ed. 1980), pp. 939-947.
Cecil, Textbook of Medicine, (15th Ed. 1979), pp. 731-732.
Cohen et al., Hypertension, 5, 676, (1983).
Berde, The Medical Journal of Australia, Special Supplement, Nov. 4, 1978, pp. 3-13.
Fanciullacci et al., Headache, 16, 226, (1976).
Calesnick, AFP, 25, 228, (1982).
Awouters, 5-Hydroxytryptamine in Perpheral Reactions, (Raven Press, N.Y., 1982), pp. 71-75.
Aellig, Eur. J. Clin. Pharm., 25, 759, (1983).
Sulman et al., Headache, 17, 203, (1979).
Amano et al., ibid, 22, 249, (1982).
Cohen et al., J.P.E.T., 227, 327, (1983).
Lance, Brit. Med. J., 1970, (2), 327.
Friedman, Headache, 11, 148, (1972).
Saxena, ibid, 12, 44, (1972).
Lance and Anthony, Proc. Aust. Assoc. Neurol., 7, 32, (1970).
Prusinski et al., Pol. J. Pharmacol. Pharm., 37, Suppl. 189-193.
Cohen Marlene L.
Fuller Ray W.
Abramson F.
Eli Lilly and Company
Friedman Stanley J.
Rowe James L.
Whale Arthur R.
LandOfFree
Selective method for blocking 5HT.sub.2 receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective method for blocking 5HT.sub.2 receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective method for blocking 5HT.sub.2 receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-111932